PensionDanmark Pensionsforsikringsaktieselskab Increases Stake in Agilent Technologies, Inc. $A

PensionDanmark Pensionsforsikringsaktieselskab boosted its position in Agilent Technologies, Inc. (NYSE:A) by 9.6% during the 2nd quarter, Holdings Channel reports. The fund owned 83,766 shares of the medical research company’s stock after acquiring an additional 7,371 shares during the quarter. PensionDanmark Pensionsforsikringsaktieselskab’s holdings in Agilent Technologies were worth $11,127,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the company. Fiduciary Trust Co lifted its position in shares of Agilent Technologies by 1.6% during the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after buying an additional 77 shares during the last quarter. Freestone Capital Holdings LLC raised its stake in Agilent Technologies by 2.0% during the 4th quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock worth $574,000 after acquiring an additional 84 shares in the last quarter. Sapient Capital LLC lifted its position in Agilent Technologies by 4.2% in the first quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock valued at $240,000 after acquiring an additional 85 shares during the last quarter. Plan A Wealth LLC lifted its position in Agilent Technologies by 3.2% in the fourth quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock valued at $403,000 after acquiring an additional 92 shares during the last quarter. Finally, IHT Wealth Management LLC boosted its stake in Agilent Technologies by 4.9% in the fourth quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock valued at $278,000 after acquiring an additional 96 shares in the last quarter.

Agilent Technologies Price Performance

Shares of A opened at $146.04 on Friday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27. The firm has a 50-day simple moving average of $134.16 and a 200-day simple moving average of $125.18. The company has a market capitalization of $41.25 billion, a price-to-earnings ratio of 29.32, a price-to-earnings-growth ratio of 2.51 and a beta of 1.25.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post 6.01 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were issued a $0.255 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s payout ratio is presently 20.48%.

Analyst Ratings Changes

Several brokerages have issued reports on A. Sanford C. Bernstein assumed coverage on Agilent Technologies in a report on Friday, June 26th. They set an “outperform” rating and a $155.00 price objective on the stock. Barclays upped their target price on Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research report on Wednesday, June 24th. Robert W. Baird raised their price target on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 26th. Jefferies Financial Group initiated coverage on Agilent Technologies in a research note on Thursday, July 9th. They issued a “hold” rating and a $135.00 price objective for the company. Finally, HSBC lowered their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $159.35.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.